Topics to be discussed:
- Downfall of Menopausal Hormone Therapy (MHT) & the Impact on the Management of Vasomotor Symptoms
- Limitations of Nonhormonal Pharmacotherapy: Consequences and Considerations
- NK3 and NK1 Antagonism: Mechanism of Action and Considerations for Application
- Holistic Approach to Address Menopausal Symptoms and Improve Quality of Life
- Application to Clinical Practice — Integrating Neurokinin Inhibitors and Holistic Care into the Current Clinical Setting
